Cover Image

Integrating Clinical and Societal Perspectives on Prostate Cancer Research: Addressing Key Limitations and Future Directions

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yuekun Fang, Shengyi Chen, Bin Cheng
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	The Prostate
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
by: Shengyi Chen, et al.
Published: (2025)

Therapeutic Exhaustion After Upfront Androgen Receptor Signaling Inhibitor: A Hidden Determinant of Post‐CRPC Survival
by: Shengyi Chen, et al.
Published: (2026)

Limitations and Implications: Revisiting the Clinical Relevance of Ductal Features in Abiraterone‐Treated Prostate Cancer
by: Wenjing Xie, et al.
Published: (2026)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

Restoration of Mitochondrial Function: A Metabolic Perspective on “Directed Evolution” in Castration‐Resistant Prostate Cancer
by: Po‐Jung Su, et al.
Published: (2026)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
by: Haotian Chen, et al.
Published: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
by: Yitong Weng, et al.
Published: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
by: Cameron J. Britton, et al.
Published: (2025)

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
by: Penglu Yang, et al.
Published: (2025)

Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate Cancer
by: Robert A. Gatenby, et al.
Published: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
by: Tatsuya Shimomura, et al.
Published: (2026)

Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis
by: Tomoya Hatayama, et al.
Published: (2026)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
by: Yuto Ono, et al.
Published: (2025)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
by: Victor Sandoval, et al.
Published: (2025)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
by: Yifu Shi, et al.
Published: (2025)

Evidence and Rationale for Prostate Cancer Screening
by: Takeshi Takahashi
Published: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)

Altered Glycosylation of PSA in Prostate Cancer Tissue
by: Hannu Koistinen, et al.
Published: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
by: Andrea K. Miyahira, et al.
Published: (2024)

Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
by: Cevat İlteriş Kıkılı, et al.
Published: (2026)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
by: Reid Vassallo, et al.
Published: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
by: Erum Z. Whyne, et al.
Published: (2025)

Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
by: Takanori Tokunaga, et al.
Published: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
by: Charly Bâcle, et al.
Published: (2025)

Outcome Differences Between Subgroups of Favorable Intermediate Risk Prostate Cancer After Radical Prostatectomy
by: Matthew T. Steidle, et al.
Published: (2026)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
by: Kristofer G. Taylor, et al.
Published: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
by: Muhammad Umair, et al.
Published: (2026)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
by: Christian P. Pavlovich, et al.
Published: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
by: Ahmed Yehia Abdelaziz, et al.
Published: (2024)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
by: Christian Andrés Martínez Osorio, et al.
Published: (2025)

Preliminary Evidence on Safety and Clinical Efficacy of Luteolin for Patients With Prostate Cancer Under Active Surveillance
by: Taku Naiki, et al.
Published: (2025)

Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort
by: Yuanchu J. Yang, et al.
Published: (2025)

Integration of Primary Care Into the Follow‐Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region
by: Angel Borque‐Fernando, et al.
Published: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
by: Andrea K. Miyahira, et al.
Published: (2024)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
by: Marta Victoria Lorenzo‐Sánchez, et al.
Published: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
by: Yu‐Hsiang Lin, et al.
Published: (2025)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
by: Anwar E. Ahmed, et al.
Published: (2025)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
by: Y. M. Yáñez‐Castillo, et al.
Published: (2025)